China Top 60 Biopharmaceutical Manufacturing Directory, 2nd Ed February 2017
The completely updated, comprehensive Top 60 Directory provides detailed profiles of China biopharmaceutical facilities, including information on their capacity, history, products, scale, management, business focus, products, R&D, business and partnering strategies, strengths and weaknesses, and future objectives. The directory also highlights current and upcoming facilities, and includes information on key marketed and clinical trial products.
Top 60 Biopharmaceutical Facilities in China Directory allows readers to keep up-to-date on new and existing biopharmaceutical facilities as the industry continues to grow and expand. This newly updated directory helps you stay aware of current key participants, as well as new and upcoming facilities in this rapidly changing market.
This second edition of BioPlan Associates’ facilities directory of major biopharmaceutical manufacturing facilities in China covers facilities with the most bioprocessing capacity (total bioreactor volumes), and those under active construction. Facility information includes
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook